TherapeuticsMD (TXMD) Total Liabilities (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Total Liabilities came in at $10.6 million in Q1 2026, down 7.72% YoY from $11.5 million in Q1 2025, and down 1.6% on a QoQ basis from $10.8 million in Q4 2025.
TherapeuticsMD (TXMD) Total Liabilities (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Total Liabilities data on file, last reported at $10.6 million in Q1 2026.
- Quarterly Total Liabilities fell 7.72% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (down 7.72% YoY) and the FY2025 annual result came in at $10.8 million, down 5.87% from the prior year.
- Total Liabilities eased to $10.6 million in Q1 2026, from $10.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $274.0 million in Q1 2022 to a low of $10.6 million in Q1 2026.
- A 5-year average of $51.5 million and a median of $13.4 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities advanced 10.12% — and 2023, when it plunged 89.93%.
- Tracing TXMD's Total Liabilities over 5 years: stood at $55.3 million in 2022, then tumbled by 74.65% to $14.0 million in 2023, then retreated by 18.33% to $11.5 million in 2024, then fell by 5.87% to $10.8 million in 2025, then declined by 1.6% to $10.6 million in 2026.
- The last three Total Liabilities figures came in at $10.6 million (Q1 2026), $10.8 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.12 Bn |
| 10 | TherapeuticsMD | 23.78 Mn | 14.60 Mn | - | 10.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.40 Mn |
| Mar 31, 2026 | 10.61 Mn |
| Dec 31, 2025 | 10.78 Mn |
| Sep 30, 2025 | 11.23 Mn |
| Jun 30, 2025 | 11.21 Mn |
| Mar 31, 2025 | 11.50 Mn |
| Dec 31, 2024 | 11.45 Mn |
| Sep 30, 2024 | 12.46 Mn |
| Jun 30, 2024 | 12.46 Mn |
| Mar 31, 2024 | 13.42 Mn |
| Dec 31, 2023 | 14.02 Mn |
| Sep 30, 2023 | 22.44 Mn |
| Jun 30, 2023 | 22.49 Mn |
| Mar 31, 2023 | 27.58 Mn |
| Dec 31, 2022 | 55.32 Mn |
| Sep 30, 2022 | 182.18 Mn |
| Jun 30, 2022 | 172.27 Mn |
| Mar 31, 2022 | 273.96 Mn |
| Dec 31, 2021 | 263.09 Mn |
| Sep 30, 2021 | 266.99 Mn |